Evolocumab Use In Patients With Human Immunodeficiency Virus And Dyslipidemia: Final Results Of The Open Label Extension Period (Beijerinck)

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2021)

Cited 0|Views1
No score
Key words
human immunodeficiency virus,open label extension period
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined